ArticleFrontiers in immunology2026
Perinatal morphine exposure induces chromatin and transcriptomic remodeling to alter immune and metabolic function.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: Infants exposed to opioids in utero are at risk of developing Neonatal Opioid Withdrawal Syndrome (NOWS). Rodent models of perinatal opioid exposure can reliably recapitulate the acute withdrawal and developmental deficits exhibited in clinical NOWS, but few persisting phenotypes are consistently observed between studies, limiting mechanistic insight into the long-lasting effects of early-life opioid exposure. Methods: To investigate the enduring impact of perinatal opioid exposure, we employed a multi-region, multi-omic approach. We combined RNA sequencing (RNA-seq) and H3K27ac chromatin immunoprecipitation sequencing (ChIP-seq) from NeuN+ neuronal nuclei in a mouse model of NOWS. Additionally, cytokine levels were measured in the brain and spleen, and physiological responses were assessed under both basal and immune-challenged conditions. Results: Analysis revealed differentially expressed genes and H3K27ac modifications were enriched for immune and metabolic pathways in hypothalamic neurons. Transcription factor network inference identified state-dependent rewiring of immune and metabolic regulatory circuits, with Transcription factor 4 (TCF4) emerging as a convergent epigenomic and transcriptional hub under immune-challenged conditions. Consistent with molecular signatures, cytokine levels were suppressed in morphine-exposed mice both in adulthood, both at baseline and under immune-challenged conditions. Several metabolic properties, including changes in weight and basal body temperature, were also altered. Discussion: Our findings suggest that perinatal opioid exposure creates a lasting enhancer imprint in hypothalamic neurons, leading to suppressed baseline immune gene expression and altered regulatory responses to subsequent inflammatory challenges. These epigenomic and transcriptional changes may underlie the long-term physiological impacts of early-life opioid exposure, offering new insights into the enduring consequences of NOWS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.